NeuroPace Inc
NPCE· Nasdaq
Filed Nov 8, 2022 · 10-Q · 39 days after period end · 0001528287-22-000027
| Metric | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|
| Revenue | $11.16M | $10.34M | $12.77M |
| Net Income | -$11.79M | -$8.08M | -$4.13M |
| EPS Diluted | -$0.48 | -$0.34 | -$19.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NeuroPace Inc · CIK 1528287 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 8, 2022 · 39 d after period end